Juan J. Sancho-Alegre

Gaspar Aguilar Avenue, 90
Valencia, VC 46017, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Utility of total gastrointestinal transit scintigraphy in the evaluation of patients with VEDOSS and systemic sclerosis.

Utility of total gastrointestinal transit scintigraphy in the evaluation of patients with VEDOSS and systemic sclerosis.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: May 12, 2026

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains.

Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains.

Journal: Clinical rheumatology

Published: January 19, 2026

Nailfold capillaroscopy improves cardiovascular risk stratification in SSc: an adjustment of the SCORE2 algorithm.

Nailfold capillaroscopy improves cardiovascular risk stratification in SSc: an adjustment of the SCORE2 algorithm.

Journal: Rheumatology (Oxford, England)

Published: January 08, 2026

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Journal: RMD open

Published: December 22, 2025

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature review.

Journal: RMD open

Published: December 22, 2025

Response to letter to the editor regarding "Nailfold Capillaroscopy as a predictor of cardiovascular events and mortality in systemic sclerosis".

Response to letter to the editor regarding "Nailfold Capillaroscopy as a predictor of cardiovascular events and mortality in systemic sclerosis".

Journal: Seminars in arthritis and rheumatism

Published: December 19, 2025

Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

Real-World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity-Matched Study From the EUSTAR Cohort.

Journal: Arthritis care & research

Published: December 01, 2025

VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.

VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.

Journal: Seminars in arthritis and rheumatism

Published: November 14, 2025

Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.

Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.

Journal: The Journal of rheumatology

Published: November 05, 2025

Cervical spinal calcinosis in systemic sclerosis presenting with foraminal stenosis, radiculopathy and vertebral artery displacement.

Cervical spinal calcinosis in systemic sclerosis presenting with foraminal stenosis, radiculopathy and vertebral artery displacement.

Journal: Clinical and experimental rheumatology

Published: October 31, 2025

Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.

Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.

Journal: The Journal of rheumatology

Published: October 01, 2025

The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort.

The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort.

Journal: Therapeutic advances in musculoskeletal disease

Published: September 23, 2025

Showing 1-12 of 81

Last Updated: 09/26/2026